Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06782100 · ClinicalTrials.gov registry record
MRI Guided Management of Occlusive Peripheral Arterial Disease
A clinical trial of Peripheral Vascular Diseases, sponsored by The Methodist Hospital Research Institute.
- Recruiting
- Registry status
- 175
- Enrollment target
- 1
- Study location
NCT06782100 is a study of Peripheral Vascular Diseases that is actively recruiting participants, run by The Methodist Hospital Research Institute. The registered enrollment target is 175 participants, below the 487-participant average among 19 other Peripheral Vascular Diseases trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06782100, a study of Peripheral Vascular Diseases, is actively recruiting participants, sponsored by The Methodist Hospital Research Institute.
- RECRUITING
- Registry status
- 175 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational study is to identify which plaque lesions in patients with peripheral arterial disease are impenetrable and to determine which devices minimize vessel wall injury. Patients undergoing intervention will have an MRI scan prior to their planned percutaneous vascular intervention to assess the plaque and predict procedural difficulty. Patients undergoing lower limb amputation due to peripheral arterial disease will have their limbs included into a second arm of the study The limb will undergo an MRI scan to assess the plaque. The investigator will then test two different devices and assess the effects of these devices on the vessel wall.
Conditions Studied
Study Locations (1)
Texas
- Houston Methodist Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2024-07-01 |
| Est. Completion | 2029-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06782100
The ClinicalTrials.gov registry entry for NCT06782100 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 175 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 487-participant average among 19 other Peripheral Vascular Diseases trials with a reported enrollment target (64% lower). The listed sponsor is The Methodist Hospital Research Institute, which has 126 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Peripheral Vascular Diseases appearing as the primary indexed condition, and to 0 interventions.
NCT06782100 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06782100 about?
NCT06782100 is a clinical study titled "MRI Guided Management of Occlusive Peripheral Arterial Disease". The goal of this observational study is to identify which plaque lesions in patients with peripheral arterial disease are impenetrable and to determine which devices minimize vessel wall injury. Patients undergoing intervention will have an MRI scan prior to their planned percutaneous vascular inte...
What is the current status of trial NCT06782100?
This trial is currently recruiting. The enrollment target is 175 participants. The study started on 2024-07-01. Estimated completion is 2029-06.
What conditions does trial NCT06782100 study?
This clinical trial studies the following conditions: Peripheral Vascular Diseases.
Who is sponsoring clinical trial NCT06782100?
This trial is sponsored by The Methodist Hospital Research Institute, which has 126 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06782100 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Vascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effects of ATLAS Therapy on Nitric Oxide Bioavailability in Patients With Intermittent Claudication
RECRUITING · Phase 1
-
Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy
RECRUITING · NA
-
Impact of Nrf2 Activation on Macrovascular, Microvascular & Leg Function & Walking Capacity in Peripheral Artery Disease
RECRUITING · Early Phase 1
-
Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 2
RECRUITING · NA
-
Fisetin to Reduce Senescence and Mobility Impairment in PAD
RECRUITING · Phase 2
-
Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 3
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.